Workflow
BIO-key(BKYI)
icon
Search documents
Humanity International Investments Hits Major Milestones in Digital Identity with the Humanity Protocol Initiative in Partnership with BIO-key International
Newsfilter· 2024-03-12 18:17
DUBAI, United Arab Emirates and HOLMDEL, N.J., March 12, 2024 (GLOBE NEWSWIRE) -- Humanity International Investments (HII) and BIO-key® International, Inc. (NASDAQ:BKYI), announce significant milestones in HII's innovative Humanity Protocol initiative. Over 40,000 NFTs have been claimed to date, showcasing the project making remarkable strides in digital identity and blockchain technology integration. Humanity International Investments, under the Chairmanship of His Highness, Sheikh Marwan bin Mohamed bin R ...
Tragsa Group Enhances Cybersecurity with BIO-key's Multi-Factor Authentication Solution
Newsfilter· 2024-01-22 10:15
MADRID, Spain and HOLMDEL, N.J., Jan. 22, 2024 (GLOBE NEWSWIRE) -- BIO-key® International, Inc. (NASDAQ:BKYI), an innovative provider of workforce and customer Identity and Access Management (IAM) featuring passwordless, phoneless and token-less Identity-Bound Biometric (IBB) authentication solutions, today announced that Spain's Grupo Tragsa (the Tragsa Group) has partnered with Factum España to implement BIO-key's AuthControl Sentry solution. AuthControl Sentry, renowned for its comprehensive authenticati ...
Haver & Boecker Implements Single Sign-On (SSO) with Multifactor Authentication via P&W Netzwerk and BIO-key Europe to Secure and Streamline User Access
Newsfilter· 2024-01-17 09:59
HOLMDEL, N.J. and OELDE, Germany, Jan. 17, 2024 (GLOBE NEWSWIRE) -- BIO-key® International, Inc. (NASDAQ:BKYI), an innovative provider of workforce and customer Identity and Access Management (IAM) solutions featuring Identity-Bound Biometric (IBB) authentication solutions, today announced that Haver & Boecker, a global leader in processing and packaging technology for bulk materials, has implemented Multifactor Authentication (MFA) and Single Sign-On (SSO) technology for its digital platforms via P&W Netzw ...
BIO-key(BKYI) - 2023 Q3 - Quarterly Report
2023-11-19 16:00
FORM 10-Q For the quarterly period ended September 30, 2023 or ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(D) OF THE EXCHANGE ACT Commission file number 1-13463 DELAWARE 41-1741861 (State or Other Jurisdiction of Incorporation of Organization) (IRS Employer Identification Number) (Address of Principal Executive Offices) Securities registered pursuance to Section 12(b) of the Act: Common Stock, par value $0.0001 per share BKYI Nasdaq Capital Market Indicate by check mark whether the registrant has submitted e ...
BIO-key(BKYI) - 2023 Q2 - Quarterly Report
2023-08-17 16:00
FORM 10-Q Commission file number 1-13463 (732) 359-1100 (Registrant's telephone number, including area code) Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐ If an emerging growth company, indicate by chec ...
BIO-key(BKYI) - 2023 Q2 - Earnings Call Transcript
2023-08-15 17:36
BIO-key International, Inc. (NASDAQ:BKYI) Q2 2023 Earnings Conference Call August 15, 2023 10:00 AM ET Company Participants Bill Jones – Investor Relations Mike DePasquale – Chairman and Chief Executive Officer Ceci Welch – Chief Financial Officer Conference Call Participants Jack Vander Aarde – Maxim Group Operator Good morning, everyone. Thank you for standing by, and welcome to BIO-key International Second Quarter 2023 Conference Call. During management’s prepared remarks all participants will be in list ...
BIO-key(BKYI) - 2023 Q1 - Quarterly Report
2023-06-08 16:00
☐ TRANSITION REPORT UNDER SECTION 13 OR 15(D) OF THE EXCHANGE ACT 3349 HIGHWAY 138, BUILDING A, SUITE E, WALL, NJ 07719 (Address of Principal Executive Offices) Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ ...
BIO-key(BKYI) - 2022 Q4 - Annual Report
2023-05-31 16:00
● International law enforcement use case applications as prospects see us as a global leader in the biometric technology space as witnessed by our agreement with the Israeli Defense Force, and the Singapore and Dubai Police departments. 4 We sell our products directly through our field and inside sales teams, as well as indirectly through our network of channel partners. Through our Channel Alliance Program, we have partnered with more than 40 resellers, system integrators and other distribution partners. W ...
BIO-key(BKYI) - 2023 Q1 - Earnings Call Transcript
2023-05-16 17:06
BIO-key International, Inc. (NASDAQ:BKYI) Q1 2023 Results Conference Call May 16, 2023 10:00 AM ET Company Participants William Jones - Catalyst IR Michael DePasquale - Chairman and CEO Cecilia Welch - CFO Conference Call Participants Jack Vander Aarde - Maxim Group Operator Good morning, everyone. Thank you for standing by, and welcome to the BIO-key International's First Quarter 2023 Conference Call. [Operator Instructions]. As a reminder, this conference call is being recorded today, Tuesday, May 16, 202 ...
BIO-key(BKYI) - 2022 Q4 - Earnings Call Transcript
2023-03-31 18:30
BIO-key International, Inc. (NASDAQ:BKYI) Q4 2022 Earnings Conference Call March 31, 2023 10:00 AM ET Company Participants William Jones - Catalyst IR Michael DePasquale - Chairman and CEO Galen Rodgers - VP of Channels Cecilia Welch - CFO Conference Call Participants Jack Vander Aarde - Maxim Group Operator Good morning, ladies and gentlemen. Thank you for standing by, and welcome to the BIO-key International Fourth Quarter Conference Call. During management's prepared remarks, all participants will be in ...